Spironolactone
Product Images NDC 53002-1707

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 53002-1707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021707)

Spironolactone 50 mg tablets packaging label from RPK Pharmaceuticals, Inc., NDC 53002-1707. The label includes spaces for patient name, directions to take the tablet as prescribed, quantity, refills, and prescriber information. It shows a bottle count of 30 tablets and highlights that this is a prescription-only medication.*

FDA Label Image

20 (Spironolactone Tablets Usp 1)

Chemical structure diagram of Spironolactone, showing its molecular framework with characteristic ring systems and functional groups as typically presented in pharmaceutical labeling.*

FDA Label Image

10 (Spironolactone Tablets Usp 2)

A Kaplan-Meier survival curve graph comparing the probability of event-free survival over a period of up to 48 months for two groups: one treated with Spironolactone (n=822) and the other with placebo (n=841). The x-axis represents time in months, and the y-axis shows probability from 0 to 1, with a log-rank p-value less than 0.001 indicating statistical significance between groups.*

FDA Label Image

2 (Spironolactone Tablets Usp 3)

A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups including age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, and medication use. The plot compares outcomes between Spironolactone and placebo, with Spironolactone favored on the left side of the graph and placebo favored on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.